Idarubicin HCL Intermediates 2

N-(Trifluoroacetyl)-1-desmethyl Daunorubicin is a derivative of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression.

Price Not Available inquiry Idarubicin HCL Intermediates 2 Supplier Page

Catalog Number	INT68594069
Alternative Name(s)	N-(Trifluoroacetyl)-1-desmethyl Daunorubicin N-[(2S,3S,4S,6R)-6-[[(1S,3S)-3-acetyl-3,5,10,12-tetrahydroxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-2,2,2-trifluoroacetamide DTXSID40570353 (1S,3S)-3-Acetyl-3,5,10,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-alpha-L-lyxo-hexopyranoside
Research Area	Intermediates
Molecular Formula	C28H26F3NO11
CAS#	68594-06-9
SMILES	CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)O)O)(C(=O)C)O)NC(=O)C(F)(F)F)O
Size	inquiry
Supplier Page	https://www.protheragen-ing.com/idarubicin-hcl-intermediates-2-item-12068.html